Self-dissolving microneedles for the percutaneous absorption of EPO in mice

References

• Abels R. Erythropoietin for anaemia in cancer patients. Eur J Cancer 1993; 29A(Suppl 2)S2–S8
   PubMed Web of Science ®Google Scholar
• Ambrose CG, Clanto TO. Bioabsorbable implants: Review of clinical experience in orthopedic surgery. Ann Biomed Eng 2004; 32(1)171–177
   PubMed Web of Science ®Google Scholar
• Amino Y, Kawada K, Toi K, Kumashiro I, Fukushima K. Phenylalanine derivatives enhancing intestinal absorption of EPO in mice. Chem Pharm Bull 1988; 36: 4426–4434
   PubMed Web of Science ®Google Scholar
• Barry B, Williams A. Penetration enhancers. Adv Drug Deliv Rev 2003; 56: 603–618
   Web of Science ®Google Scholar
• Bleuel H, Hoffman R, Kaufman B, Neubert P, Ochlich PP, Schaumann W. Kinetics of subcutaneous versus intravenous epoetin-beta in dogs, rats and mice. Pharmacology 1996; 52: 329–338
   PubMed Web of Science ®Google Scholar
• Case DC, Jr, Bukowski RM, Carey RW, et al. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 1993; 85: 801–806
   PubMed Web of Science ®Google Scholar
• Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 2004; 56: 675–711
   PubMed Web of Science ®Google Scholar
• Chandrasekaran S, Brazzle JD, Frazier AB. Surface micromachined metallic microneedles. J Microelectromech Syst 2003; 12(3)281–288
   Web of Science ®Google Scholar
• Cunha AS, Grossiord JL, Puisieux F, Seiller M. EPO in W/O/W multiple emulsions: Biological activity after oral administration in normal and diabetic rats. J Microencapsul 1997; 14: 321–333
   PubMed Web of Science ®Google Scholar
• Davis JM, Aralkawas T, Strickland TW, Yphantis DA. Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells. Biochemistry 1987; 26: 2633–2638
   PubMed Web of Science ®Google Scholar
• Demetri GD, Kris M, Wade J, Degos L, Cella D. Quality-of life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Result from a prospective community oncology study. J Clin Oncol 1998; 16: 3412–3425
   PubMed Web of Science ®Google Scholar
• Doukas A. Transdermal delivery with a pressure wave. Adv Drug Deliv Rev 2004; 56: 559–579
   PubMed Web of Science ®Google Scholar
• Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987; 316: 73–78
   PubMed Web of Science ®Google Scholar
• Goldwasser E, Kung CHK. Progress in the purification of erythropoietin. Ann N Y Acad Sci 1968; 149: 49–53
   PubMed Web of Science ®Google Scholar
• Graspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S. Impact of therapy with wpowtin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol 1997; 15: 1218–1234
   PubMed Web of Science ®Google Scholar
• Griss P, Enoksson P, Stemme G. Micromachined barbed spikes for mechanical chip attachment. Sens Acutuators A Phys 2002; 95: 94–99
   Web of Science ®Google Scholar
• Kim K, Park DS, Lu HM, Che W, Kim K, Lee JB, Ahn CH. A tapered hollow metallic microneedle array using backside exposure of SU-8. J Micromech Microeng 2004; 14: 597–603
   Web of Science ®Google Scholar
• Leitgeb C, Pecherstorfer M, Fritz E, Ludwig H. Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer 1994; 73: 2535–2542
   PubMed Web of Science ®Google Scholar
• Littlewood TJ, Bajetta E, Nortier JWR, Vercammen E, Rapoport B. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized double-blind, placebo-controlled trial. J Clin Oncol 2001; 19: 2865–2874
   PubMed Web of Science ®Google Scholar
• Ludwig H, Fritz E, Kotzmann H, Höcker P, Gisslinger H, Barnas U. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 1990; 322: 1693–1699
   PubMed Web of Science ®Google Scholar
• Ludwig H, Sundal E, Pecherstorfer M, et al. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytoxic chemotherapy. Cancer 1995; 76: 2319–2329
   PubMed Web of Science ®Google Scholar
• Maitani Y, Hazama M, Tojo Y, Simoda N, Nagai T. Oral administration of recombinant human erythropoietin in liposomes in rats: Influence of lipid composition and size of liposomes on bioavailability. J Pharm Sci 1996; 85(4)440–445
   PubMed Web of Science ®Google Scholar
• Maitani Y, Moriya H, Shimoda N, Takayama K, Nagai T. Distribution characteristics of entrapped recombinant human erythropoietin in liposomes and its intestinal absorption in rats. Int J Pharm 1999; 185: 13–22
   PubMed Web of Science ®Google Scholar
• Markham A, Bryson H. Epoetin alfa, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in non-renal applications. Drugs 1995; 49(2)232–254
   PubMed Web of Science ®Google Scholar
• Matsuzawa A, Morishita M, Takayama K, Nagai T. Absorption of EPO using water-in-oil-in-water emulsion from an enteral loop in rats. Biol Pharm Bull 1995; 18: 1718–1723
   PubMed Web of Science ®Google Scholar
• McLennan DNM, Porter CJH, Edwards GA, Martin SW, Heatherington AC, Charman SA. Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep. J Pharmacol Exp Ther 2005; 313: 345–351
   PubMed Web of Science ®Google Scholar
• Mitragotri S, Kost J. Low-frequency sonophoresis: A review. Adv Drug Deliv Rev 2004; 56: 589–601
   PubMed Web of Science ®Google Scholar
• Miyano T, Tobinaga Y, Kanno T, Matsuzaki Y, Takeda H, Wakui M, Hanada K. Sugar micro needles as transdermic drug delivery system. Biomed Microdevices 2005; 7: 185–188
   PubMed Web of Science ®Google Scholar
• Mizuno A, Ueda M, Kawanishi G. Effects of salicylate and other enhancers on rectal absorption of erythropoietin in rats. J Pharm Pharmacol 1992; 44: 570–573
   PubMed Web of Science ®Google Scholar
• Morishita I, Morishita M, Takayama K, Machida Y, Nagai T. Hypoglycemic effect of novel oral microspheres of EPO with protease inhibitor in normal and diabetic rats. Int J Pharm 1992; 78: 9–16
   Web of Science ®Google Scholar
• Morishita M, Morishita I, Takayama K, Machida Y, Nagai T. Site dependent effect of aprotinin, sodium caprate Na2EDTA and sodium glycocholate on intestinal absorption of EPO. Biol Pharm Bull 1993; 16: 68–72
   PubMed Web of Science ®Google Scholar
• Morishita M, Matsuzawa A, Takayama K, Isowa K, Nagai T. Improving EPO enteral absorption using water-in-oil-in-water emulsion. Int J Pharm 1998; 172: 189–198
   Web of Science ®Google Scholar
• Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004; 56: 581–587
   PubMed Web of Science ®Google Scholar
• Preat V, Vanbever R. Skin electroporation for transdermal and topical delivery. Adv Drug Deliv Rev 2004; 56: 659–674
   PubMed Web of Science ®Google Scholar
• Shimoda N, Maitani Y, Machida Y, Nagai T. Effects of dose, pH and osmolarity on intranasal absorption of recombinant human erythropoietin in rats. Biol Pharm Bull 1995; 18(5)734–739
   PubMed Web of Science ®Google Scholar
• Spivak J. Recombinant human erythropoietin and the anaemia of cancer. Blood 1994; 84(4)997–1004
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y. Enteral absorption of EPO in rats from mucoadhesive Chitosan coated liposomes. Pharm Res 1996; 13: 896–901
   PubMed Web of Science ®Google Scholar
• Teo MAL, Shearwood C, Ng KC, Lu J, Moochhala S. In vitro and in vivo characterization of MEMS microneedles. Biomed Microdevices 2005; 7(1)47–52
   PubMed Web of Science ®Google Scholar
• Tozaki H, Komoike J, Tada C, Maruyama T, Terabe A, Suzuki J. Chitosan capsules for colon-specific drug delivery: Improvement of EPO absorption from the rat colon. J Pharm Sci 1997; 86: 1016–1021
   PubMed Web of Science ®Google Scholar
• Urabe A, Takaku T, Mizoguchi H, Kubo K, Ota K, Shimizu N, Tanaka K, Miura N, Nihei H, Koshikawa S, Akizawa T, Akiyama N, Otsubo O, Kawaguchi Y, Maeda T. Effect of recombinant human erythropoietin on the anemia of chronic renal failure. Int J Cell Cloning 1988; 6: 179–191
   PubMedGoogle Scholar
• Utoguchi N, Watanabe Y, Shida T, Matsumoto M. Nitric oxide donors enhance rectal absorption of macromolecules in rabbits. Pharm Res 1998; 15: 870–876
   PubMed Web of Science ®Google Scholar
• Winerals CG, Olivar DO, Pippard MJ, Reid C, Downing MR, Cotes PR. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet ii 1986; 1175–1177
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Taniguchi T, Rikyuu K, Tsuji T, Murakami M, Muranishi S. Effects of various protease inhibitors on the intestinal absorption and degradation of EPO in rats. Pharm Res 1994; 11: 1496–1500
   PubMed Web of Science ®Google Scholar
• Zahn JD, Talbot NH, Pisano AP, Liepman D. Microfabricated polysilicon microneedles for minimally invasive biomedical devices. Biomed Microdevices 2000; 2(4)295–303
   Web of Science ®Google Scholar